{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:17:11Z","timestamp":1783487831628,"version":"3.55.0"},"reference-count":70,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/etm.2016.3566","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T09:29:19Z","timestamp":1470302959000},"page":"1951-1956","source":"Crossref","is-referenced-by-count":36,"title":["Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches"],"prefix":"10.3892","volume":"12","author":[{"given":"Wen-Juan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"key20180108132747_b1-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"key20180108132747_b2-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"key":"key20180108132747_b3-etm-0-0-3566","volume-title":"Huntington's disease","author":"Bates","year":"2002"},{"key":"key20180108132747_b4-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"key20180108132747_b5-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","year":"2015","journal-title":"Cell"},{"key":"key20180108132747_b6-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"key20180108132747_b7-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00230496","article-title":"The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy","volume":"85","author":"Mann","year":"1993","journal-title":"Acta Neuropathol"},{"key":"key20180108132747_b8-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"key20180108132747_b9-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1098\/rstb.1971.0102","article-title":"The structure of the caudate nucleus of the cat: Light and electron microscopy","volume":"262","author":"Kemp","year":"1971","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key20180108132747_b10-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0006-8993(84)91224-1","article-title":"The striatopallidal and striatonigral projections: Two distinct fiber systems in primate","volume":"303","author":"Parent","year":"1984","journal-title":"Brain Res"},{"key":"key20180108132747_b11-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","article-title":"Cortical and striatal neurone number in Huntington's disease","volume":"88","author":"Heinsen","year":"1994","journal-title":"Acta Neuropathol"},{"key":"key20180108132747_b12-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20180108132747_b13-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","article-title":"Huntington's disease genetics","volume":"1","author":"Myers","year":"2004","journal-title":"NeuroRx"},{"key":"key20180108132747_b14-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet"},{"key":"key20180108132747_b15-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","article-title":"Instability of CAG repeats in Huntington's disease: Relation to parental transmission and age of onset","volume":"31","author":"Trottier","year":"1994","journal-title":"J Med Genet"},{"key":"key20180108132747_b16-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","article-title":"Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm","volume":"6","author":"Telenius","year":"1994","journal-title":"Nat Genet"},{"key":"key20180108132747_b17-etm-0-0-3566","first-page":"2547","article-title":"Cardiac dysfunction in huntington's disease","volume":"20","author":"Zielonka","year":"2014","journal-title":"Exp Clin Cardiol"},{"key":"key20180108132747_b18-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fphys.2014.00380","article-title":"Skeletal muscle pathology in Huntington's disease","volume":"5","author":"Zielonka","year":"2014","journal-title":"Front Physiol"},{"key":"key20180108132747_b19-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: From pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem J"},{"key":"key20180108132747_b20-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington's Disease: A genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol Neurobiol"},{"key":"key20180108132747_b21-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","article-title":"Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis","volume":"12","author":"Kennedy","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key20180108132747_b22-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nn.4014","article-title":"REGISTRY Investigators of the European Huntington's Disease Network: A SNP in the HTT promoter alters NF-\u03baB binding and is a bidirectional genetic modifier of Huntington disease","volume":"18","author":"Be\u010danovi\u0107","year":"2015","journal-title":"Nat Neurosci"},{"key":"key20180108132747_b23-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"key20180108132747_b24-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat Genet"},{"key":"key20180108132747_b25-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat Genet"},{"key":"key20180108132747_b26-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: Relevance to Huntington's disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J Cell Sci"},{"key":"key20180108132747_b27-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"key":"key20180108132747_b28-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108132747_b29-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp Neurol"},{"key":"key20180108132747_b30-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: Posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"key20180108132747_b31-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington's disease: Advances in care and emerging therapeutic options","volume":"21","author":"Zielonka","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"key20180108132747_b32-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation","volume":"137","author":"Jeong","year":"2009","journal-title":"Cell"},{"key":"key20180108132747_b33-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/pmic.201100380","article-title":"Mass spectrometric identification of novel posttranslational modification sites in Huntingtin","volume":"12","author":"Dong","year":"2012","journal-title":"Proteomics"},{"key":"key20180108132747_b34-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"key20180108132747_b35-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","article-title":"Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons","volume":"17","author":"Zala","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key20180108132747_b36-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington's disease","volume":"27","author":"Venuto","year":"2012","journal-title":"Mov Disord"},{"key":"key20180108132747_b37-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"e27746","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"key":"key20180108132747_b38-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat Genet"},{"key":"key20180108132747_b39-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"Suppl 10","key":"key20180108132747_b40-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"S47.004","DOI":"10.1212\/WNL.82.10_supplement.S47.004","article-title":"Safety and tolerability of selisistat for the treatment of huntington's disease: Results from a randomized, double-blind, placebo-controlled phase II trial","volume":"82","author":"Reilmann","year":"2014","journal-title":"Neurology"},{"key":"key20180108132747_b41-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: Underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"key20180108132747_b42-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1074\/jbc.R109.072181","article-title":"Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases","volume":"285","author":"Renna","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180108132747_b43-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nchembio.582","article-title":"Kinase inhibitors modulate huntingtin cell localization and toxicity","volume":"7","author":"Atwal","year":"2011","journal-title":"Nat Chem Biol"},{"key":"key20180108132747_b44-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/ncb1477","article-title":"The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions","volume":"8","author":"Tam","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key20180108132747_b45-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.1222663110","article-title":"Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes","volume":"110","author":"Sontag","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108132747_b46-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key20180108132747_b47-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element-mediated transcription: An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180108132747_b48-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","article-title":"Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species","volume":"54","author":"Coskran","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"key20180108132747_b49-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.110.173294","article-title":"Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease","volume":"336","author":"Kleiman","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108132747_b50-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/mds.26007","article-title":"Targets for future clinical trials in Huntington's disease: What's in the pipeline?","volume":"29","author":"Wild","year":"2014","journal-title":"Mov Disord"},{"key":"key20180108132747_b51-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol Dis"},{"key":"key20180108132747_b52-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nn.2346","article-title":"Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin","volume":"12","author":"Morfini","year":"2009","journal-title":"Nat Neurosci"},{"key":"key20180108132747_b53-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.nbd.2011.12.019","article-title":"P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease","volume":"45","author":"Fan","year":"2012","journal-title":"Neurobiol Dis"},{"key":"key20180108132747_b54-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","article-title":"MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition","volume":"33","author":"Taylor","year":"2013","journal-title":"J Neurosci"},{"key":"key20180108132747_b55-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice","volume":"39","author":"Apostol","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"key20180108132747_b56-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1136\/jnnp-2014-309032.5","article-title":"A05 targeting kmo: Basic understanding and gaps","volume":"85","author":"Mrzljak","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20180108132747_b57-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gene.2005.09.011","article-title":"Designer zinc-finger proteins and their applications","volume":"366","author":"Papworth","year":"2006","journal-title":"Gene"},{"key":"key20180108132747_b58-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/ene.12366","article-title":"Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls","volume":"21","author":"Jiang","year":"2014","journal-title":"Eur J Neurol"},{"key":"key20180108132747_b59-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"E3136","DOI":"10.1073\/pnas.1206506109","article-title":"Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6\/2 mice","volume":"109","author":"GarrigaCanut","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108132747_b60-etm-0-0-3566","first-page":"7052","article-title":"Allele- specific repression of mutant Huntingtin expression by engineered zinc finger transcriptional repressors as a potential therapy for Huntington's disease","volume":"108","author":"Zeitler","year":"2011","journal-title":"PNAS"},{"key":"key20180108132747_b61-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"key20180108132747_b62-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"key20180108132747_b63-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","article-title":"\u2018Huntingtin holiday\u2019: Progress toward an antisense therapy for Huntington's disease","volume":"74","author":"Lu","year":"2012","journal-title":"Neuron"},{"key":"key20180108132747_b64-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol Ther"},{"key":"key20180108132747_b65-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/108729003764097296","article-title":"Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells","volume":"13","author":"Miyagishi","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"key20180108132747_b66-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2005.02.024","article-title":"Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108132747_b67-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108132747_b68-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drudis.2014.09.011","article-title":"Delivering a disease-modifying treatment for Huntington's disease","volume":"20","author":"Godinho","year":"2015","journal-title":"Drug Discov Today"},{"key":"key20180108132747_b69-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann Neurol"},{"key":"key20180108132747_b70-etm-0-0-3566","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2016.01.021","article-title":"Use of human stem cells in Huntington disease modeling and translational research","volume":"278","author":"Golas","year":"2016","journal-title":"Exp Neurol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3566\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:49:49Z","timestamp":1718732989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,4]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/etm.2016.3566"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3566","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}